ASBP β€” ASPIRE BIOPHARMA HLDGS INC

Ownership history in Antara Capital LP  Β·  2 quarters on record

This page tracks every 13F SEC filing in which Antara Capital LP reported a position in ASPIRE BIOPHARMA HLDGS INC (ASBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
88.65% (2025 Q4)
πŸ“Š Avg. % of fund
48.59%
πŸ“… First filed
2025 Q3
πŸ“… Last filed
2025 Q4
⏱ Quarters held
2
% of Fund (quarterly)    ASBP price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 202,897 β€” 0% 88.65% $26.8M $5.28
2025 Q3 INITIATED 202,897 β€” β€” 8.53% $41.8M $8.24

🏒 Other funds also holding ASBP

As of 2025 Q4 β€” sorted by position size

Optivise Advisory Services LLC 0.03% Crewe Advisors LLC 3Y 7Y 0.01% Resolute Advisors LLC 3Y 0.01% Scientech Research LLC 0.0% P SCHOENFELD ASSET MANAGEMENT LP 3Y 7Y 0.0% VR Advisory Services Ltd 3Y 7Y 0.0% Procyon Advisors, LLC 3Y 0.0% Avion Wealth 3Y 0.0% Platform Technology Partners 3Y 0.0% XTX Topco Ltd 3Y 0.0%
← Back to Antara Capital LP Holdings